Incorporated in 1995, Mankind Pharma Limited develops, manufactures, and markets pharmaceutical formulations in various acute and chronic therapeutic areas and several consumer healthcare products. Presenting below are its Q1 FY26 earnings results.
Q1 FY26 Earnings Results
-
Consolidated Revenue: ₹3,570.35 crores, up 24.4% YoY (Q1 FY25: ₹2,867.85 crores).
-
Profit After Tax (PAT): ₹445 crores, down 18% YoY (Q1 FY25: ₹536.49 crores).
-
EBITDA: ₹850 crores, EBITDA margin at 23.8%, up 20 basis points YoY.
-
Profit Before Tax (PBT): ₹926.65 crores, up from ₹770.96 crores YoY.
-
Standalone Revenue: ₹2,541.36 crores, up 5.3% YoY, PAT ₹412.76 crores, down 13.4% YoY.
-
Earnings Per Share (EPS): ₹10.62, down 20.69% YoY (Q1 FY25: ₹13.40).
-
Domestic Business Revenue: ₹3,101 crores, up 18.9% YoY, driven by steady base business and Bharat Serums and Vaccines (BSV) consolidation.
-
Export & Consumer Healthcare Business: ₹469 crores (up 81.1% YoY), ₹237 crores (up 15% YoY) respectively.
-
Increase in Costs: Higher employee expenses, increased R&D investments, and raw material costs impacted profit margins.
Management Commentary & Strategic Highlights
-
The decline in net profit was attributed to increased input and operational costs alongside investments in growth initiatives like R&D and talent.
-
Strong growth in chronic therapies, consumer healthcare segment, and consolidation of BSV contributed to overall revenue growth.
-
Management expressed confidence in healthy performance continuation backed by niche specialty portfolio and market expansion.
-
The board declared an interim dividend of ₹1 per share to reward shareholders on the company’s 30th anniversary.
Q4 FY25 Earnings Results
-
Revenue: ₹3,079 crores.
-
Profit After Tax: ₹425 crores.
-
EBITDA Margin: Approximately 24%.
-
EPS: ₹10.2.
To view the company’s previous earnings and latest concall transcripts, click here to visit the Alphastreet India news channel.
Most Popular
Cochin Shipyard Ltd (COCHINSHIP) Q4 FY22 Earnings Concall Transcript
Cochin Shipyard Limited (NSE:COCHINSHIP) Q4 FY22 Earnings Concall dated May. 26, 2022 Corporate Participants: Madhu S Nair -- Chairman & Managing Director Jose V J -- Director Finance Analysts: Vastupal Shah
All you need to know about Antony Waste Handling Cell in one article
Can you guess the name of the company that was listed during the IPO frenzy in 2020 and is the second largest player in the Indian municipal waste management industry?
Demystifying the Leading Non-Ferrous Recycling Company of India
“Hey, how is the market doing today?” “Oh!, its falling tremendously since morning” I am sure news like these might be a common topic of discussion for you nowadays. Interestingly,